Buy or sell Genomind stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Genomind Stock
Genomind is a personalized medicine company specializing in neuropsychiatry.
About Genomind Stock
Genomind is a personalized medicine company specializing in neuropsychiatry. It was founded by a psychiatrist, Dr. Ronald Dozoretz, and a neurologist, Dr. Jay Lombard, who share a common goal of wanting the best possible care for patients who suffer from psychiatric illness. It was founded in 2009 and headquartered in Chalfont, Pennsylvania.
Funding History
| April 2014 | $20.9M |
|---|---|
| April 2016 | $17.9M |
| July 2016 | $3.0M |
| February 2017 | $11.0M |
| July 2018 | $500K |
| September 2020 | $20.6M |
Management
Founder
Ronald I. Dozoretz
Director of Behavioral Science
Francis Brennan
Advisor
Stephen Stahl
Advisor
Scott Aaronson
Advisor
Anil Malhotra
Advisor
Allan Levey
Advisor
Rudolph Tanzi
CEO
Cynthia Kilroy
Chairman of the Board of Directors
Ronald I. Dozoretz
Chief Medical Officer
David Krause
Advisor
Murali Doraiswamy
Advisor
Roy Perlis
Chief Information Officer
Jon Levine
Chief Scientific Officer
David Robbins
US Sales Leader
Laura Miles
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
